Open Government Portal
Guidance document provides applicants seeking authorization to conduct COVID-19 drug clinical trials specifically around the applications guidelines and process.
IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential …
Learn more about drugs and vaccines being developed or authorized for COVID-19.
The purpose of this notice is to communicate the types of testing technologies that Health Canada considers are a priority …
During the pandemic, there may be more deviations from the established protocol. Despite this, it’s important to continue to protect …
The guidance documents contain information for applicants seeking authorization to conduct COVID-19 drug and medical device clinical trials under Interim …
The data contained in the dashboard describes the COVID-19 cases and deaths by province and health regions.
The dashboard …
Appearance of Minister of Labour Standing Committee on Human Resources, Skills and Social Development and the Status of Persons with …
Honourable Ahmed Hussen, Minister of Families, Children and Social Development, at an appearance before the House of Commons, Standing Committee …The Government of Canada has put in place emergency measures to slow the introduction and spread of COVID-19 and variants …